Avalon GloboCare Corp (ALBT)

[Quintessence]

Avalon GloboCare CEO David Jin, M.D., Ph.D. to Chair and Speak at the Plenary Session of the 14th Annual World Stem Cell Summit

https://www.otcmarkets.com/stock/AVCO/news/story?e&id=1259735

Plenary Session and Presentation entitled "Status of Cellular Therapy and Regenerative Medicine in China"

FREEHOLD, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies, announced today that its President and Chief Executive Officer, David Jin, M.D., Ph.D., will chair and speak at the plenary session of the 14th Annual World Stem Cell Summit in Miami, Florida. The presentation is entitled, "Status of Cellular Therapy and Regenerative Medicine in China."
Session information:
Date: January 24, 2019
Time: 9:20 a.m. ET
Venue: Hyatt Regency Miami

"Avalon GloboCare is dedicated to assembling and integrating the premier scientific, clinical, and regulatory resources from around the world, in order to accelerate innovative and transformative cellular technologies and their clinical applications," stated Dr. David Jin. "We are honored to lead a panel with leading experts from the U.S. and China to discuss an evolving ecosystem of cellular therapy and regenerative medicine. We look forward to sharing our experiences and capabilities in cell-based technologies and therapeutics," added Dr. Jin.